Microinjection of calpastatin inhibits fusion in myoblasts

Constance J. Temm-Grove, David Wert, V. F. Thompson, Ronald E Allen, Darrel E. Goll

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Rat satellite cells (RSC) were microinjected with purified calpastatin or m-calpain, and myoblasts from a C2C12 mouse line were microinjected with purified calpastatin. Microinjection with calpastatin completely prevented fusion of myoblasts from both sources, whereas microinjection with m-calpain significantly increased the rate of fusion of cultured RSC; 44% of the nuclei of RSC cultures were in multinucleated myotubes within 48 h after microinjection with m-calpain plus labeled dextran, whereas only 15% of the nuclei were in multinucleated myotubes after microinjection with dextran alone. Western analyses indicated that neither RSC nor C2C12 myoblasts contained detectable amounts of μ-calpain before fusion. The levels of calpastatin in C2C12 myoblasts increased as cells passed from the proliferative stage to the onset of fusion, and these levels increased substantially in both the C2C12 and the RSC cells as they progressed to the late or postfusion stage. Both RSC and C2C12 myoblasts contained an 80-kDa polypeptide that was labeled with an anti-m-calpain antibody in Western blots. The results are consistent with a role of the calpain system (m-calpain in these myoblast lines) in remodeling of the cytoskeletal/plasma membrane interactions during cell fusion.

Original languageEnglish (US)
Pages (from-to)293-303
Number of pages11
JournalExperimental Cell Research
Volume247
Issue number1
DOIs
StatePublished - Feb 25 1999

Fingerprint

Myoblasts
Microinjections
Calpain
Skeletal Muscle Fibers
Dextrans
Cell Fusion
Cell Nucleus
calpastatin
Cell Culture Techniques
Western Blotting
Cell Membrane
m-calpain
Peptides
Antibodies

Keywords

  • Calpain
  • Calpastatin
  • Microinjection
  • Myoblast fusion
  • Satellite cells

ASJC Scopus subject areas

  • Cell Biology

Cite this

Microinjection of calpastatin inhibits fusion in myoblasts. / Temm-Grove, Constance J.; Wert, David; Thompson, V. F.; Allen, Ronald E; Goll, Darrel E.

In: Experimental Cell Research, Vol. 247, No. 1, 25.02.1999, p. 293-303.

Research output: Contribution to journalArticle

Temm-Grove, CJ, Wert, D, Thompson, VF, Allen, RE & Goll, DE 1999, 'Microinjection of calpastatin inhibits fusion in myoblasts', Experimental Cell Research, vol. 247, no. 1, pp. 293-303. https://doi.org/10.1006/excr.1998.4362
Temm-Grove, Constance J. ; Wert, David ; Thompson, V. F. ; Allen, Ronald E ; Goll, Darrel E. / Microinjection of calpastatin inhibits fusion in myoblasts. In: Experimental Cell Research. 1999 ; Vol. 247, No. 1. pp. 293-303.
@article{cb4ffeb30adf4ddcadd97129e51b36af,
title = "Microinjection of calpastatin inhibits fusion in myoblasts",
abstract = "Rat satellite cells (RSC) were microinjected with purified calpastatin or m-calpain, and myoblasts from a C2C12 mouse line were microinjected with purified calpastatin. Microinjection with calpastatin completely prevented fusion of myoblasts from both sources, whereas microinjection with m-calpain significantly increased the rate of fusion of cultured RSC; 44{\%} of the nuclei of RSC cultures were in multinucleated myotubes within 48 h after microinjection with m-calpain plus labeled dextran, whereas only 15{\%} of the nuclei were in multinucleated myotubes after microinjection with dextran alone. Western analyses indicated that neither RSC nor C2C12 myoblasts contained detectable amounts of μ-calpain before fusion. The levels of calpastatin in C2C12 myoblasts increased as cells passed from the proliferative stage to the onset of fusion, and these levels increased substantially in both the C2C12 and the RSC cells as they progressed to the late or postfusion stage. Both RSC and C2C12 myoblasts contained an 80-kDa polypeptide that was labeled with an anti-m-calpain antibody in Western blots. The results are consistent with a role of the calpain system (m-calpain in these myoblast lines) in remodeling of the cytoskeletal/plasma membrane interactions during cell fusion.",
keywords = "Calpain, Calpastatin, Microinjection, Myoblast fusion, Satellite cells",
author = "Temm-Grove, {Constance J.} and David Wert and Thompson, {V. F.} and Allen, {Ronald E} and Goll, {Darrel E.}",
year = "1999",
month = "2",
day = "25",
doi = "10.1006/excr.1998.4362",
language = "English (US)",
volume = "247",
pages = "293--303",
journal = "Experimental Cell Research",
issn = "0014-4827",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Microinjection of calpastatin inhibits fusion in myoblasts

AU - Temm-Grove, Constance J.

AU - Wert, David

AU - Thompson, V. F.

AU - Allen, Ronald E

AU - Goll, Darrel E.

PY - 1999/2/25

Y1 - 1999/2/25

N2 - Rat satellite cells (RSC) were microinjected with purified calpastatin or m-calpain, and myoblasts from a C2C12 mouse line were microinjected with purified calpastatin. Microinjection with calpastatin completely prevented fusion of myoblasts from both sources, whereas microinjection with m-calpain significantly increased the rate of fusion of cultured RSC; 44% of the nuclei of RSC cultures were in multinucleated myotubes within 48 h after microinjection with m-calpain plus labeled dextran, whereas only 15% of the nuclei were in multinucleated myotubes after microinjection with dextran alone. Western analyses indicated that neither RSC nor C2C12 myoblasts contained detectable amounts of μ-calpain before fusion. The levels of calpastatin in C2C12 myoblasts increased as cells passed from the proliferative stage to the onset of fusion, and these levels increased substantially in both the C2C12 and the RSC cells as they progressed to the late or postfusion stage. Both RSC and C2C12 myoblasts contained an 80-kDa polypeptide that was labeled with an anti-m-calpain antibody in Western blots. The results are consistent with a role of the calpain system (m-calpain in these myoblast lines) in remodeling of the cytoskeletal/plasma membrane interactions during cell fusion.

AB - Rat satellite cells (RSC) were microinjected with purified calpastatin or m-calpain, and myoblasts from a C2C12 mouse line were microinjected with purified calpastatin. Microinjection with calpastatin completely prevented fusion of myoblasts from both sources, whereas microinjection with m-calpain significantly increased the rate of fusion of cultured RSC; 44% of the nuclei of RSC cultures were in multinucleated myotubes within 48 h after microinjection with m-calpain plus labeled dextran, whereas only 15% of the nuclei were in multinucleated myotubes after microinjection with dextran alone. Western analyses indicated that neither RSC nor C2C12 myoblasts contained detectable amounts of μ-calpain before fusion. The levels of calpastatin in C2C12 myoblasts increased as cells passed from the proliferative stage to the onset of fusion, and these levels increased substantially in both the C2C12 and the RSC cells as they progressed to the late or postfusion stage. Both RSC and C2C12 myoblasts contained an 80-kDa polypeptide that was labeled with an anti-m-calpain antibody in Western blots. The results are consistent with a role of the calpain system (m-calpain in these myoblast lines) in remodeling of the cytoskeletal/plasma membrane interactions during cell fusion.

KW - Calpain

KW - Calpastatin

KW - Microinjection

KW - Myoblast fusion

KW - Satellite cells

UR - http://www.scopus.com/inward/record.url?scp=0033602032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033602032&partnerID=8YFLogxK

U2 - 10.1006/excr.1998.4362

DO - 10.1006/excr.1998.4362

M3 - Article

VL - 247

SP - 293

EP - 303

JO - Experimental Cell Research

JF - Experimental Cell Research

SN - 0014-4827

IS - 1

ER -